CGEM vs CL · $830.3M cap vs P/E 34, rev $20.38B
Cullinan Oncology LLC (CGEM) versus Colgate-Palmolive Company (CL) — a side-by-side from cached financials, not a winner call.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
CGEM currently screens at market cap $830.3M. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Not investment advice. Open the CGEM and CL stock pages for the full models.
Not investment advice.